Biotech IPOs; don’t let the numbers deceive

Biotech IPOs; don’t let the numbers deceive
Take the biotechnology industry, which in 2003 raised $16.7 billion in capital — its second-best year ever. Yet, many of the biotech companies that went public in the last quarter of the year were miserable after-market performers.


Leave a Reply

Your email address will not be published. Required fields are marked *